|
| Source | Engineering treatments | Infusion method | Outcome | Reference |
|
1 | M-ADMSCs | macrophages | IP | ↓ mortality and weight loss, inflammatory cytokines | [24] |
|
2 | H-GMSCs | Acetylsalicylic Acid | | ↓ disease phenotypes | [59] |
|
3 | M-BMMSCs | Aspirin | IV | ↓DAI and colonic inflammation | [45] |
|
4 | H-UCB-MSCs | DNA methyltransferase | | ↑ therapeutic effect of MSCs | [51] |
|
5 | R-BMMSCs | G-CSF | IV | ↓ DAI, MPO activity, serum TNF-a and NF-κB p65 | [60] |
|
6 | H-ADMSCs | HCB platelet lysate | enema | ↓ colitis scores, inflamed area and inflammatory mediators. | [61] |
|
7 | M-BMMSCs | Heparin | IV | ↓ mortality,weight loss, inflammation reaction and tissue injury | [62] |
|
8 | H-UCMSCs | IFN-γ overexpression | IV | ↓ the ease of body weight,↑ colon length, ↓DAI, and↑ small intestine tissues structure | [49] |
|
9 | M-BMMSCs | Inhibition of Gal-3 | IP | ↑ therapeutic potential | [63] |
|
10 | M-BMMSCs | Insulin-like Growth Factor Binding Protein 7 | IV and IP | ↓ clinical and histopathological severity | [64] |
|
11 | H-BMMSCs | knocking down let-7a | IV | ↑ therapeutic potential | [65] |
|
12 | H-BMMSCs | low doses of ultraviolet radiation and X-rays | | ↑ the effect of radiotherapy in CRC | [66] |
|
13 | M-BMMSCs | MicroRNA Let-7a Knockdown | IV | ↓ mortality, ↓ weight loss,↓ inflammation reaction,↓ tissue lesion | [65] |
|
14 | R-ADMSCs | miR-1236 knock down | enema | ↓ inflammation markers | [23] |
|
15 | Microvesicles M-BMSCs | miR-200b overexpression | IV | ↑ the colon fibrosis histologically | [67] |
|
16 | M-BMMSCs | miR-21 Knockdown | IV | ↑ colonic inflammation in a TGF-b1-dependent manner | [48] |
|
17 | R-BMMSCs | Over-expression CXCR4 | IV | ↓ both clinical and microanatomical severity of colitis | [50] |
|
18 | H-UCMSCs | Poly (I:C) | IP | ↑ clinical and pathological manifestations | [68] |
|
19 | M-BMMSCs | Poly(I:C) | IP | ↓ the pathologic severity | [69] |
|
20 | H-UCMSCs | poly(I:C) and LPS | IP | ↓ clinical signs of disease, colon shortening and histological disease | [53] |
|
21 | R/H-BMMSCs | melatonin | IV | ↑ therapeutic effect | [55] |
|
22 | M-BMMSCs | spheroid formation | Intraluminal | ↓ body weight loss and ↓ DAI | [57] |
|
23 | H-BMSCs | Spheroidal formation | IP | simplify long-distance transportation and ↑ therapeutic application | [56] |
|
24 | BMMSCs | transfect with sodium iodide symporter | IV | ↓ tumor growth and ↑ overall survival | [66] |
|
25 | R-BMMSCs | Tregs | IV | ↓clinical and histopathologic severity | [10] |
|
26 | M-BMMSCs | Tregs cell | IV | ↑ body weight and ↑ colon morphology | [70] |
|